Preparation of fatty acid-RGD-fatty alcohol conjugate mediated epirubicin targeted liposome and evaluation on anticancer activity

A technology targeting liposomes and fatty acids, which is applied in the field of biomedicine and can solve the problems that ordinary liposomes do not have targeting properties

Inactive Publication Date: 2012-07-04
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Ordinary liposomes are not targeted

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation of fatty acid-RGD-fatty alcohol conjugate mediated epirubicin targeted liposome and evaluation on anticancer activity
  • Preparation of fatty acid-RGD-fatty alcohol conjugate mediated epirubicin targeted liposome and evaluation on anticancer activity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Example 1CH 3 (CH 2 ) 10 CO-Arg-Gly-Asp-OCH 2 (CH 2 ) 10 CH 3 preparation of

[0045] 1) Preparation of Boc-Arg(NO2)-Gly-OBzl

[0046] 1.59 g (5 mmol) Boc-Arg(NO2)-OH, 0.68 g (5 mmol) N-hydroxybenzotriazole (HOBt) were dissolved in anhydrous THF. 1.34 g (5.75 mmol) of anhydrous THF solution of dicyclohexylcarbodiimide (DCC) was added dropwise under ice bath, and stirred for 20 minutes under ice bath to obtain reaction solution (I). Suspend 1.69g (5.0mmol) TosOH·Gly-OBzl in an appropriate amount of anhydrous DMF under ice-cooling, then add a few drops of N-methylmorpholine (NMM) to adjust the pH to 7-8 to obtain the reaction solution (II) . Add the reaction solution (I) dropwise to the reaction solution (II) under ice bath, first stir under ice bath for 1 h, then stir at room temperature for 12 h, TLC (chloroform / methanol, 10:1) shows that Boc-Arg(NO2)-OH disappears , stop responding. Dicyclohexylurea (DCU) was filtered off, and the filtrate was blown off of D...

Embodiment 2

[0062] Embodiment 2. The preparation of epirubicin liposome (2)

[0063] Prepared by ammonium sulfate gradient method. Take an appropriate amount of phospholipids and cholesterol into a round bottom flask and dissolve them in chloroform, and remove the solvent by rotary evaporation, forming a transparent film on the bottle wall. 150mmol·L -1 (NH 4 ) 2 SO 4 The solution was added to the lipid film, and ultrasonically dispersed to obtain a blank liposome suspension. Put the blank liposome in the dialysis bag for dialysis 4-5 times, each time for about 10 hours, take out the dialysis liquid and place it in an eggplant bottle; in addition, accurately weigh an appropriate amount of epirubicin, dissolve it in water, and add this solution to Place the blank liposome suspension in a hot water bath and shake it from time to time. After taking out from the hot water bath, the epirubicin liposome is obtained.

[0064] Particle size 150~250nm, Zeta-Potential-20~-40mV.

Embodiment 3

[0065] Example 3. Containing CH in the membrane material 3 (CH 2 ) 10 CO-GGD-OCH 2 (CH 2 ) 10 CH 3 Preparation of epirubicin liposomes (3)

[0066] The dosage of each component: epirubicin 2-8%; natural lecithin, cholesterol and CH 3 (CH 2 ) 10 CO-GGD-OCH 2 (CH 2 ) 10 CH 3 The mixture 90-97%, in this mixture, natural lecithin 70-80% (mass percentage), cholesterol 10-20% (mass percentage) and compound CH 3 (CH 2 ) 10 CO-GGD-OCH 2 (CH 2 ) 10 CH 3 3-10% (mass percentage).

[0067] Take phospholipids, cholesterol and CH 3 (CH 2 ) 10 CO-GGD-OCH 2 (CH 2 ) 10 CH 3 Dissolve in chloroform in a round-bottomed flask, remove the solvent by rotary evaporation, and form a transparent film on the bottle wall. 150mmol·L -1 (NH 4 ) 2 SO 4 The solution was added to the lipid film, and ultrasonically dispersed to obtain a blank liposome suspension. Place the blank liposome in the dialysis bag for dialysis 4-5 times, each time for about 10 hours, take out the dialy...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses preparation of fatty acid-RGD-fatty alcohol conjugate mediated epirubicin targeted liposome and evaluation on anticancer activity. According to the invention, the conjugate has the following structural formula: CH3(CH2)nCO-Arg-Gly-Asp-OCH2(CH2)10CH3, wherein n is equal to 4-16. An anticancer medicine is introduced into the conjugate to obtain anticancer targeted liposome medicine; the liposome can increase the concentration of the anticancer medicine at a target position, reduce the toxic and side effects of the anticancer medicine at a non-target position, and improve the therapeutic index of the medicine.

Description

technical field [0001] The present invention relates to a targeted drug release carrier, in particular to a fatty acid-RGD-fatty alcohol-mediated targeted drug carrier and its construction method. The present invention also relates to the application of a drug carrier in the preparation of targeted anti-tumor drug liposomes, which belongs to biological field of medicine. Background technique [0002] The growth and metastasis of many malignant tumors are related to abnormal expression of integrins or changes in molecular structure. Integrins are a large family of transmembrane proteins, consisting of α and β subunits to form heterodimers. At present, it has been found that there are about 18 kinds of α, about 8 kinds of β, and at least 24 kinds of integrin forms of heterodimers. The progression of integrins in tumors may be dual: 1) In the early stage of tumorigenesis, the reduction of integrin expression can weaken the adhesion between tumor cells and basement membrane or...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K5/09C07K1/113A61K47/42A61K9/127A61K31/337A61K31/704A61P35/00
Inventor 崔国辉崔纯莹吴曼
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap